Gambro, the Swedish medical technology group controlled by the Wallenberg family, yesterday confirmed the sale of its US dialysis clinics business to DaVita and also unveiled a far-reaching strategic alliance with its former rival.

DaVita, based in California, will pay a total of $3.05bn in cash for Gambro's US business, which includes 565 clinics serving 43,200 patients across the country.